Peter J. M. Openshaw

Research.com Recognitions

• Fellow of The Academy of Medical Sciences, United Kingdom
• Fellow of The Academy of Medical Sciences, United Kingdom
• Fellow of The Academy of Medical Sciences, United Kingdom
• Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Best Publications

• Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.

  Annemarie B Docherty;Ewen M Harrison;Christopher A Green;Hayley E Hardwick

  3418
  Citations

• Genetic mechanisms of critical illness in Covid-19.

  E. Pairo-Castineira;E. Pairo-Castineira;S. Clohisey;L. Klaric;A. D. Bretherick

  1445
  Citations

• Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score.

  Stephen R. Knight;Antonia Ho;Riinu Pius;Iain Buchan

  1030
  Citations

• Respiratory Syncytial Virus

  Akhilesh Jha;Hannah Jarvis;Clementine Fraser;Peter Jm Openshaw

  1021
  Citations

• IFITM3 restricts the morbidity and mortality associated with influenza

  Aaron R. Everitt;Simon Clare;Thomas Charles Pertel;Sinu P. John

  907
  Citations

• Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations.

  Peter Openshaw;Erin E. Murphy;Nancy A. Hosken;Vernon Maino

  677
  Citations

• Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study.

  Olivia V Swann;Olivia V Swann;Karl A Holden;Lance Turtle;Lance Turtle;Louisa Pollock

  672
  Citations

• Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.

  Rachael A Evans;Hamish McAuley;Ewen M Harrison;Aarti Shikotra

  624
  Citations

• Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.

  Emma C. Thomson;Emma C. Thomson;Laura E. Rosen;James G. Shepherd;Roberto Spreafico

  579
  Citations

• Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus.

  M. J. Cannon;P. J. M. Openshaw;B. A. Askonas

  573
  Citations

• Reversibility of T helper 1 and 2 populations is lost after long-term stimulation.

  E Murphy;K Shibuya;N Hosken;P Openshaw

  544
  Citations

• Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis.

  Ting Shi;Angeline Denouel;Anna K Tietjen;Iain Campbell

  489
  Citations

• The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.

  Natalie I Mazur;Deborah Higgins;Marta C Nunes;José A Melero

  471
  Citations

• Tracheostomy in the COVID-19 era: global and multidisciplinary guidance.

  Brendan A McGrath;Michael J Brenner;Stephen J Warrillow;Vinciya Pandian

  440
  Citations

• Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection

  Peter J. M. Openshaw;John S. Tregoning

  432
  Citations

• DISTINCT TYPES OF LUNG-DISEASE CAUSED BY FUNCTIONAL SUBSETS OF ANTIVIRAL T-CELLS

  W. H. Alwan;W. J. Kozlowska;P. J. M. Openshaw

  403
  Citations

• Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology.

  Tracy Hussell;Alasdair Pennycook;Peter J. M. Openshaw

  383
  Citations

• Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009).

  J S Nguyen-Van-Tam;P J M Openshaw;A Hashim;E M Gadd

  331
  Citations

• Flow cytometric measurement of intracellular cytokines.

  Pietro Pala;Tracy Hussell;Peter J.M. Openshaw

  328
  Citations

• Age at First Viral Infection Determines the Pattern of T Cell–mediated Disease during Reinfection in Adulthood

  Fiona J. Culley;Joanne Pollott;Peter J.M. Openshaw

  321
  Citations

• Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.

  Clark D Russell;Cameron J Fairfield;Thomas M Drake;Lance Turtle

  310
  Citations

• Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus.

  Maximillian S. Habibi;Agnieszka Jozwik;Spyridon Makris;Jake Dunning

  304
  Citations

• Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants.

  C. R. M. Bangham;P. J. M. Openshaw;L. A. Ball;A. M. Q. King

  290
  Citations

• Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G.

  Peter J. M. Openshaw;Sarah L. Clarke;Fiona M. Record

  286
  Citations

• CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection.

  Tracy Hussell;Christopher J. Baldwin;Anne O'Garra;Peter J. M. Openshaw

  283
  Citations

• Genetic mechanisms of critical illness in Covid-19

  Erola Pairo-Castineira;Sara Clohisey;Lucija Klaric;Andrew Bretherick;Andrew Bretherick

  98
  Citations

• Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score

  Stephen R Knight;Antonia Ho;Riinu Pius;Iain Buchan

  54
  Citations